Jueng Soo You

3.6k total citations · 1 hit paper
46 papers, 2.5k citations indexed

About

Jueng Soo You is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jueng Soo You has authored 46 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Jueng Soo You's work include Epigenetics and DNA Methylation (18 papers), Genomics and Chromatin Dynamics (9 papers) and Histone Deacetylase Inhibitors Research (7 papers). Jueng Soo You is often cited by papers focused on Epigenetics and DNA Methylation (18 papers), Genomics and Chromatin Dynamics (9 papers) and Histone Deacetylase Inhibitors Research (7 papers). Jueng Soo You collaborates with scholars based in South Korea, United States and United Kingdom. Jueng Soo You's co-authors include Peter A. Jones, Peter A. Jones, Daniel D. De Carvalho, Gangning Liang, Phillippa C. Taberlay, Theresa K. Kelly, Mi Jeong Heo, Sang Geon Kim, Pau Sancho‐Bru and Delia Blaya and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jueng Soo You

45 papers receiving 2.5k citations

Hit Papers

Cancer Genetics and Epigenetics: Two Sides of the Same Coin? 2012 2026 2016 2021 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jueng Soo You South Korea 23 2.0k 459 269 247 208 46 2.5k
Wai Kit Chu Hong Kong 28 1.7k 0.8× 308 0.7× 389 1.4× 235 1.0× 139 0.7× 98 2.8k
Qi Ding China 24 1.4k 0.7× 467 1.0× 510 1.9× 196 0.8× 189 0.9× 96 2.1k
Feizhen Wu China 24 2.8k 1.4× 837 1.8× 228 0.8× 317 1.3× 279 1.3× 51 3.4k
Jeong‐Heon Lee United States 33 2.8k 1.4× 376 0.8× 219 0.8× 388 1.6× 304 1.5× 84 3.5k
Dominique Joubert France 29 1.4k 0.7× 353 0.8× 443 1.6× 300 1.2× 119 0.6× 68 2.4k
Mirang Kim South Korea 24 1.2k 0.6× 439 1.0× 200 0.7× 161 0.7× 146 0.7× 58 1.7k
Andy J. Chien United States 27 2.6k 1.3× 234 0.5× 542 2.0× 197 0.8× 226 1.1× 43 3.2k
Rodolfo Iuliano Italy 28 1.7k 0.8× 631 1.4× 327 1.2× 331 1.3× 519 2.5× 75 2.6k
Ke Guo China 28 2.1k 1.1× 565 1.2× 457 1.7× 137 0.6× 514 2.5× 68 3.1k

Countries citing papers authored by Jueng Soo You

Since Specialization
Citations

This map shows the geographic impact of Jueng Soo You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jueng Soo You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jueng Soo You more than expected).

Fields of papers citing papers by Jueng Soo You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jueng Soo You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jueng Soo You. The network helps show where Jueng Soo You may publish in the future.

Co-authorship network of co-authors of Jueng Soo You

This figure shows the co-authorship network connecting the top 25 collaborators of Jueng Soo You. A scholar is included among the top collaborators of Jueng Soo You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jueng Soo You. Jueng Soo You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Myoung Jun, et al.. (2025). αKG-induced oxidative stress and mTOR inhibition as a therapeutic strategy for liver cancer. Medical Oncology. 42(4). 105–105. 2 indexed citations
2.
You, Jueng Soo, et al.. (2022). Senescence and impaired DNA damage responses in alpha-synucleinopathy models. Experimental & Molecular Medicine. 54(2). 115–128. 43 indexed citations
3.
Lee, Mingyu, Daekee Lee, Jueng Soo You, et al.. (2021). PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition. Cancers. 13(8). 1772–1772. 17 indexed citations
4.
Lee, Su Jin, Jueng Soo You, Yong Joo Kim, et al.. (2021). IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria. Scientific Reports. 11(1). 2942–2942. 6 indexed citations
5.
Kim, Sang Yean, Qingyu Shen, Hyung Seok Kim, et al.. (2021). SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer. Oncogene. 40(28). 4652–4662. 22 indexed citations
6.
Ha, Sang Yun, Ji Eun Won, Hee Dong Han, et al.. (2020). Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer. Cancer Research. 81(2). 356–370. 19 indexed citations
7.
Lee, Sang-Yong, Hyuk Soon Kim, Myoung Jun Kim, et al.. (2020). Glutamine metabolite α-ketoglutarate acts as an epigenetic co-factor to interfere with osteoclast differentiation. Bone. 145. 115836–115836. 28 indexed citations
8.
You, Jueng Soo, et al.. (2019). SOX9 is controlled by the BRD4 inhibitor JQ1 via multiple regulation mechanisms. Biochemical and Biophysical Research Communications. 511(4). 746–752. 7 indexed citations
9.
Lee, Jun‐Ho, Jueng Soo You, Seung Taek Nam, et al.. (2017). JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis. BMB Reports. 50(12). 640–646. 28 indexed citations
10.
Becket, Elinne, Sameer Chopra, Christopher E. Duymich, et al.. (2016). Identification of DNA Methylation–Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma. Cancer Research. 76(7). 1954–1964. 29 indexed citations
11.
Yi, Sang Ah, Sung Hee Um, Jaecheol Lee, et al.. (2016). S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis. Molecular Cell. 62(3). 443–452. 71 indexed citations
12.
Eun, Jung Woo, Qingyu Shen, Wahn Soo Choi, et al.. (2016). Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer. Oncotarget. 7(22). 32628–32640. 42 indexed citations
13.
Kim, Hyuk Soon, Hyuk Soon Kim, Aram Kim, et al.. (2015). Interleukin-10–producing CD5 + B cells inhibit mast cells during immunoglobulin E–mediated allergic responses. Science Signaling. 8(368). ra28–ra28. 23 indexed citations
14.
Bang, So‐Young, So Hee Kwon, Sang‐Hoon Yi, et al.. (2014). Epigenetic Activation of the Foxa2 Gene Is Required for Maintaining the Potential of Neural Precursor Cells to Differentiate into Dopaminergic Neurons After Expansion. Stem Cells and Development. 24(4). 520–533. 17 indexed citations
15.
You, Jueng Soo & Jeong Hwan Han. (2014). Targeting components of epigenome by small molecules. Archives of Pharmacal Research. 37(11). 1367–1374. 8 indexed citations
16.
You, Jueng Soo, Daniel D. De Carvalho, Chao Dai, et al.. (2013). SNF5 Is an Essential Executor of Epigenetic Regulation during Differentiation. PLoS Genetics. 9(4). e1003459–e1003459. 38 indexed citations
17.
Carvalho, Daniel D. De, Shikhar Sharma, Jueng Soo You, et al.. (2012). DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival. Cancer Cell. 21(5). 655–667. 214 indexed citations
18.
You, Jueng Soo & Peter A. Jones. (2012). Cancer Genetics and Epigenetics: Two Sides of the Same Coin?. Cancer Cell. 22(1). 9–20. 793 indexed citations breakdown →
19.
Carvalho, Daniel D. De, Jueng Soo You, & Peter A. Jones. (2010). DNA methylation and cellular reprogramming. Trends in Cell Biology. 20(10). 609–617. 162 indexed citations
20.
You, Jueng Soo, Jaeku Kang, Dong Wan Seo, et al.. (2009). Depletion of Embryonic Stem Cell Signature by Histone Deacetylase Inhibitor in NCCIT Cells: Involvement of Nanog Suppression. Cancer Research. 69(14). 5716–5725. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026